Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Antibiotics Based on Lactate After Pancreatic Surgery
NCT05052619Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Covalent Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cefoperazone + sulbactam in Intra-abdominal infection (IAI) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Incidence rate of postoperative intra-abdominal infection at 30 days. Started Jul 2021; status: recruiting.
02
Drugs
cefoperazone + sulbactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT05052619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05052619.